...
首页> 外文期刊>BMC Infectious Diseases >Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol
【24h】

Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol

机译:布洛芬与美西林治疗非并发症性膀胱炎-一项随机对照试验研究方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Although uncomplicated cystitis is often self-limiting, most such patients will be prescribed antibiotic treatment. We are investigating whether treatment of cystitis with an NSAID is as effective as an antibiotic in achieving symptomatic resolution. This is a randomized, controlled, double blind trial following the principles of Good Clinical Practice. Women between the ages of 18 to 60 presenting with symptoms of uncomplicated cystitis are screened for eligibility. 500 women from four sites in Norway, Sweden and Denmark are allocated to treatment with 600?mg ibuprofen three times a day or 200?mg mecillinam three times a day for three days. Allocation is conducted using block randomization. The primary outcome is the number of patients who feel cured by day four as recorded in a diary. Adverse events will be handled and reported in accordance with Good Clinical Practice. If treatment of uncomplicated cystitis with ibuprofen is as effective as mecillinam for symptom relief, we can potentially reduce the use of antibiotics on a global scale. EudraCTnr: 2012-002776-14. ClinicalTrials.gov: NCT01849926 .
机译:尽管无并发症的膀胱炎通常是自限性的,但大多数此类患者将接受抗生素治疗。我们正在研究用NSAID治疗膀胱炎是否与抗生素一样有效,以达到症状缓解的目的。这是遵循良好临床规范的随机,对照,双盲试验。对年龄在18至60岁之间并发单纯性膀胱炎症状的女性进行筛查是否符合条件。来自挪威,瑞典和丹麦四个地点的500名妇女每天接受3次600 mg布洛芬或每天3次200 mg mecillinam的治疗。使用块随机化进行分配。主要结局是在日记中记录的到第四天感到cured愈的患者人数。不良事件将根据“良好临床实践”进行处理和报告。如果用布洛芬治疗单纯性膀胱炎与缓解症状的美西林一样有效,我们有可能在全球范围内减少抗生素的使用。 EudraCTnr:2012-002776-14。 ClinicalTrials.gov:NCT01849926。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号